Columbia Care Inc.

As interest rates climb and regulatory uncertainties loom, decisions on capital expenditures (capex) by cannabis MSOs (Multi-State Operators) become paramount for their future success. Are some MSOs missing out on significant growth opportunities? In his latest analysis, Pablo Zuanic, managing...

The recent equity raises by Canopy Growth (NASDAQ: CGC) and Columbia Care (OTC: CCHWF) have sparked curiosity about which multi-state operators (MSOs) may follow suit. In its latest report, Zuanic & Associates (Z&A) delves into the financial net debt metrics of 20 MSOs to identify potential...

The Florida cannabis market is experiencing impressive growth, setting the stage for the potential legalization of recreational use. As it stands, Florida's medical marijuana market already boasts an impressive valuation of over $1.4 billion with a remarkable volume growth rate...

Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions. On the day following the report, MSOS ETF (ARCA: MSOS) surged...

Cannabis companies Cresco Labs (OTC: CRLBF) and Columbia Care (OTC: CCHWF) will not be able to finalize their proposed multibillion-dollar merger due to regulatory hurdles. The Chicago-based companies failed to meet the June 30 deadline set in their agreement. They are now working together to...

Cantor Fitzgerald's Pablo Zuanic took a close look at the scenarios and permutations of the Cresco/Columbia Care deal. Cresco announced it was acquiring its rival Columbia Care for $2.1 billion in March 2022. Once the deal is finalized, Cresco Labs will become the largest...

The Analyst Columbia Care is being acquired by Cresco Labs (OTC: CRBLF), in a deal set to close by year-end. In a research note published Thursday, Cantor Fitzgerald's Pablo Zuanic kept an overweight rating for (OTC: CCHWF) with a price target of $8.37. “Due to the...